With training and planning, self-injecting your rheumatoid arthritis medication may be easier than you think.

People receiving a year of abatacept (Orencia) injections had onset of rheumatoid arthritis postponed by up to four years, researchers reported Jan. 20 in The Lancet Rheumatology. Currently, no ...

Treating high-risk people with a rheumatoid arthritis drug could help delay the condition's onset by up to 4 years, new research suggests.

Polypharmacy in RA patients is linked to increased drug interaction risks, especially with immunosuppressants, necessitating careful management and monitoring. Older age and multiple comorbidities are ...

Treating people who are at high risk of rheumatoid arthritis (RA) can delay the onset of the disease for several years, with ...

Belgian drugmaker Ablynx holds high hopes for its experimental drug to treat rheumatoid arthritis after seeing strong results in a recent clinical trial, according to Reuters. North Chicago, ...

Over 10 years, nearly 13% of patients with seronegative rheumatoid arthritis receive a new diagnosis, most often ...

Rockville, MD - This week Genentech, Biogen, and Roche, the makers of rituximab, announced that they have applied to the US Food and Drug Administration for a new indication for the treatment of ...

More than 18 million people worldwide suffer from rheumatoid arthritis, including nearly 1.5 million Americans.

Researchers find drug could delay rheumatoid arthritis by years - Rheumatoid arthritis affects about 400,000 people aged 16 and over in the UK ...